These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37481872)

  • 21. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).
    Smink BE; Mathijssen MP; Lusthof KJ; de Gier JJ; Egberts AC; Uges DR
    J Anal Toxicol; 2006 Sep; 30(7):478-85. PubMed ID: 16959142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients.
    Liu HC; Lee HT; Hsu YC; Huang MH; Liu RH; Chen TJ; Lin DL
    J Anal Toxicol; 2015; 39(6):472-80. PubMed ID: 25935159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
    Coulter C; Garnier M; Moore C
    J Anal Toxicol; 2022 Oct; 46(8):899-904. PubMed ID: 35640884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
    Cone EJ
    Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose.
    Griswold MK; Chai PR; Krotulski AJ; Friscia M; Chapman BP; Varma N; Boyer EW; Logan BK; Babu KM
    J Med Toxicol; 2017 Dec; 13(4):287-292. PubMed ID: 28971325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new LC-MS/MS confirmation method for the determination of 17 drugs of abuse in oral fluid and its application to real samples.
    Bassotti E; Merone GM; D'Urso A; Savini F; Locatelli M; Tartaglia A; Dossetto P; D'Ovidio C; de Grazia U
    Forensic Sci Int; 2020 Jul; 312():110330. PubMed ID: 32480284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction.
    Kunkel F; Fey E; Borg D; Stripp R; Getto C
    J Opioid Manag; 2015; 11(5):435-42. PubMed ID: 26535971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC-atmospheric pressure chemical ionization-MS/ MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation.
    Dams R; Murphy CM; Choo RE; Lambert WE; De Leenheer AP; Huestis MA
    Anal Chem; 2003 Feb; 75(4):798-804. PubMed ID: 12622369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of 108 illicit drugs and metabolites in bile matrix by LC-MS/MS for the toxicological testing of sudden death cases.
    Franzin M; Ruoso R; Peruch M; Stocco G; D'Errico S; Addobbati R
    Arch Toxicol; 2024 Jan; 98(1):135-149. PubMed ID: 38051366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.
    Miller KL; Puet BL; Roberts A; Hild C; Carter J; Black DL
    J Subst Abuse Treat; 2017 May; 76():36-42. PubMed ID: 28131519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
    Abou El Hassan M; Colantonio D; Likhodii S; Nassar BA
    Clin Biochem; 2021 Jul; 93():99-103. PubMed ID: 33844982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid.
    Allen KR; Azad R; Field HP; Blake DK
    Ann Clin Biochem; 2005 Jul; 42(Pt 4):277-84. PubMed ID: 15989728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High-risk drug use: epidemiological pattern through hair testing in the forensic context].
    Burgueño MJ; Sánchez S; Castro MÁ; Mateos-Campos R
    Rev Esp Salud Publica; 2019 Nov; 93():. PubMed ID: 31767827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.
    Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ
    J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in post-mortem whole blood.
    Pelletti G; Rossi F; Garagnani M; Barone R; Roffi R; Fais P; Pelotti S
    Forensic Sci Int; 2020 Jul; 312():110291. PubMed ID: 32353744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Substance abuse detection in substitution therapy : Oral fluid versus urine screening].
    Stein J; Geraedts M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1261-1268. PubMed ID: 28929198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.